Manufacturer of Active Pharmaceutical Ingredients : Macrolides/Antibacterial : Azithromycin Dihydrate Usp/EP [83905-01-5], Chloramphenicol Base BP/USP [56-75-7], Chloramphencol Palmitate BP/USP [530-43-8], Erythromycin Base BP/USP [114-07-8], Erythromycin Estolate BP/USP [3521-62-8], Erythromycin Ethyl Succinate BP/USP [41342-53-4], Erythromycin Propionate FP [134-36-1] Erythromycin Stearate BP/USP [643-22-1], Roxythromycin EP [80214-83-1], Amoxapine [14028-44-5], Bisoprolol Hemifumarate USP [104344-23-2], Calamine [1314-13-2], Chlorhexidine Gluconate 20% Solution [018472-51-0], Droperidol [548-73-2], Esmolol Hydrochloride [81161-17-3], Felodipine BP 72509-76-3 Itopride Hydrochloride [122892-31-3], Maleic Acid BP [110-16-7], Nicorandil [65141-46-0], Potassium Iodide [7681-11-0], Pregabalin [148553-50-8], Prochlorperazine Maleate BP/USP [84-02-6], Prochlorperazine Mesylate BP/USP [5132-55-8], Promethazine Teoclate BP [17693-51-5], Theophylline Sodium Glycinate USP 8[000-10-0], Trimetazidine Dihydrochloride BP/EP {13171-25-0}, Intermediates : Des Azithromycin [76801-85-9], 2-[[4-(2-Isopropoxyethoxy)Methyl]-Phenoxymethyl]Oxirane{Epoxide}, Rs 3-(Aminomethyl)-5-Methyl-Hexanoic Acid), 9-[O-(1-Methoxy-1-Methylethyl)-Oxime]-6-O-Methyl-2',4-Bis-O-(Trimethylsilyl)-Erythromyci [119699-81-9], Erythromycin Oxime [13127-18-9], Under Development : Amisulpride [71675-85-9], Anagrelide [68475-42-3], Duloxetine [116539-59-4], Ezetimibe [163222-33-1], Fluvoxamine Maleate [61718-82-9]